Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats

Gastroenterology

Volumn 119, Issue 6, 2000, Pages 1681-1691

  Alvaro, Domenico ^a   Alpini, Gianfranco ^a   Onori, Paolo ^a   Perego, Lucia ^a   Baroni, Gianluca Svegliati ^a   Franchitto, Antonio ^a   Baiocchi, Leonardo ^a   Glaser, Shannon S ^a   Le Sage, Gene ^a   Folli, Franco ^a   Gaudio, Eugenio ^a  

^a Division of Gastroenterology 'Ospedali Riuniti'   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; FAS ANTIGEN; FULVESTRANT; TAMOXIFEN;

ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ESTRADIOL BLOOD LEVEL; HORMONE SYNTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAHEPATIC BILE DUCT; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0034464275     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.20184     Document Type: Article

References (36)

1. Estrogen and androgen receptors in liver: Their role in liver disease and regeneration
2. Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function
3. Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats
4. Relation of estrogen and its receptor to rat liver growth and regeneration
5. The estrogen receptor β subtype: A novel mediator of estrogen action in neuroendocrine systems
6. ERβ: Identification and characterization of a novel human estrogen receptor
7. Cloning of a novel receptor expressed in rat prostate and ovary
8. Differential response of estrogen receptor α and β to partial estrogen agonists/antagonists
9. Estrogen receptor modulators each induce distinct conformational changes in ER α and β
10. A potent specific pure antiestrogen with clinical potential
11. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro
12. Pathobiology of biliary epithelia
13. Vanishing bile duct syndrome - From bench to bed side
14. Effect of secretin on intracellular pH regulation in isolated rat bile duct epithelial cells
15. Pathology of the biliary tree in cholestasis: Ductular reaction
16. Biliary physiology in rats with bile ductular cell hyperplasia
17. Cholinergic system modulates growth, apoptosis and secretion of cholangiocytes from bile duct ligated rats
18. Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: A structural and ultrastructural study in the rat
19. Effect of glucagon on intracellular pH regulation in isolated rat hepatocyte couplets
20. Molecular cloning and characterization of rat estrogen receptor
21. Protein measurement with the Folin phenol reagent
22. Cleavage of structural proteins during the assembly of the head of the bacteriophage T
23. Electrophoretic transfer of protein from polyacrylamide gets to nitrocellulose sheets: Procedure and some applications
24. Regulation of endocytic-transcytotic pathways and bile secretion by phosphatidyl-inositol 3-kinase in rats
25. Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion
26. Antigen expression in bile duct epithelia in cholestatic liver disease
27. Effect of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats
28. The effects of the estrogen receptor blocker faslodex (ICI 182, 780), on estrogen-accelerated bone maturation in mice
29. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: Functional difference between estrogen receptors α and β
30. Molecular mechanisms of antiestrogen action in breast cancer
31. Tamoxifen interferes with insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells
32. Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines
33. Dysregulation of apoptosis as a mechanism of liver disease: An overview
34. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma
35. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 and calmodulin
36. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis and biliary cirrhosis